• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】10208

【品名】L-Menthone; (2S,5R)-2-Isopropyl-5-methylcyclohexanone

【CA登记号】14073-97-3

【 分 子 式 】C10H18O

【 分 子 量 】154.25232

【元素组成】C 77.87% H 11.76% O 10.37%

与该中间体有关的原料药合成路线共 4 条

合成路线1

该中间体在本合成路线中的序号:(I)

Artemisin can be synthesized by several related ways: 1) The reaction of L-menthone (I) with paraformaldehyde and dimethylamine hydrochloride gives the dimethylaminomethyl derivative (II), which is cyclized with ethyl acetoacetate by means of sodium ethoxide and methyl iodide to the octahydronaphthalenone (III) (Indian J Chem 1976, 14B: 901). Epoxidation of (III) with H2O2/NaOH in methanol/water yields the epoxide (IV), which is reduced with LiAlH4 in ether to the diol (V). Selective acetylation of (V) with acetic anhydride in pyridine affords the monoacetoxy compound (VI), which is cyclized by means of lead tetraacetate, catalyzed by irradiation with white light, yielding the furo-decaline (VII). The hydrolysis of the acetoxy group of (VII) followed by oxidation with pyridinium chlorochromate (PCC) gives the ketone (VIII), which is submitted to ring opening with acidic alumina in ethyl acetate/benzene, yielding the unsaturated hydroxy ketone (IX). Hydrogenation of (IX) with H2 over Pd/C in methanol affords the corresponding saturated ketone (X), which by a Grignard methylation with methylmagnesium iodide in ether gives the diol (XI). Selective acetylation of (XI) with acetic anhydride in pyridine gives the monoacetoxy compound (XII), which is dehydrated with POCl3/pyridine to the octahydronaphthalene (XIII). The hydrolysis of (XIII) with KOH in ethanol gives the alcohol (XIV), which is submitted to ozonolysis with O3 in dichloromethane followed by cyclization with p-toluenesulfonic acid, yielding the 2-benzopyran (XVI). The photochemical oxidation of (XVI) with O2 and methylene blue in dichloromethane irradiated with an Na lamp followed by a cyclization catalyzed by p-toluenesulfonic acid affords deoxoartemisinin (XVII), which is finally oxidized with RuCl3 and NaIO4 in acetonitrile/water. 2) The alcohol (XIV) can also be obtained from artemisinic acid (XV) by methylation to the corresponding methyl ester with diazomethane and reduction with LiAlH4-NiCl2 in methanol.

1 Deshpande, V.H.; Bhonsle, J.B.; Pandey, B.; Ravindranathan, T.; New synthetic strategies towards (+)-artemisinin. Tetrahedron Lett 1994, 35, 30, 5489.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 10208 L-Menthone; (2S,5R)-2-Isopropyl-5-methylcyclohexanone 14073-97-3 C10H18O 详情 详情
(II) 10209 (3R,6S)-2-[(Dimethylamino)methyl]-6-isopropyl-3-methylcyclohexanone C13H25NO 详情 详情
(III) 10210 (4aS,5R,8S)-8-Isopropyl-5-methyl-4,4a,5,6,7,8-hexahydro-2(3H)-naphthalenone C14H22O 详情 详情
(IV) 10211 (1aS,4aS,5R,8S,8aS)-8-Isopropyl-5-methylhexahydro-1aH-naphtho[1,8a-b]oxiren-2(3H)-one C14H22O2 详情 详情
(V) 10212 (2S,4aS,5R,8S)-8-Isopropyl-5-methyloctahydro-2,8a(1H)-naphthalenediol C14H26O2 详情 详情
(VI) 10213 (2S,4aS,5R,8S,8aS)-8a-Hydroxy-8-isopropyl-5-methyldecahydro-2-naphthalenyl acetate C16H28O3 详情 详情
(VII) 10214 (3aS,6R,6aS,9S,10aR)-3,6-Dimethyldecahydro-2H-naphtho[8a,1-b]furan-9-yl acetate C16H26O3 详情 详情
(VIII) 10215 (3aS,6R,6aS,10aR)-3,6-Dimethyloctahydro-2H-naphtho[8a,1-b]furan-9(10H)-one C14H22O2 详情 详情
(IX) 10216 (4aS,5R,8S)-8-(2-Hydroxy-1-methylethyl)-5-methyl-4,4a,5,6,7,8-hexahydro-2(3H)-naphthalenone C14H22O2 详情 详情
(X) 10217 (4aS,5R,8R,8aS)-8-(2-Hydroxy-1-methylethyl)-5-methyloctahydro-2(1H)-naphthalenone C14H24O2 详情 详情
(XI) 10218 (4aS,5R,8R,8aS)-8-(2-Hydroxy-1-methylethyl)-2,5-dimethyldecahydro-2-naphthalenol C15H28O2 详情 详情
(XII) 10219 2-[(1R,4R,4aS,8aS)-7-hydroxy-4,7-dimethyldecahydro-1-naphthalenyl]propyl acetate C17H30O3 详情 详情
(XIII) 10220 2-[(1R,4R,4aS,8aS)-4,7-dimethyl-1,2,3,4,4a,5,6,8a-octahydro-1-naphthalenyl]propyl acetate C17H28O2 详情 详情
(XIV) 10221 2-[(1R,4R,4aS,8aS)-4,7-Dimethyl-1,2,3,4,4a,5,6,8a-octahydro-1-naphthalenyl]-1-propanol C15H26O 详情 详情
(XV) 10222 2-[(1R,4R,4aS,8aR)-4,7-Dimethyl-1,2,3,4,4a,5,6,8a-octahydro-1-naphthalenyl]acrylic acid; Artemisinic acid C15H22O2 详情 详情
(XVI) 10223 4-[(4R,4aS,7R,8S)-4,7-Dimethyl-4,4a,5,6,7,8-hexahydro-3H-isochromen-8-yl]-2-butanone C15H24O2 详情 详情
(XVII) 10224 (1R,4S,5R,8S,9R,12R,13R)-1,5,9-Trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.0(4,13).0(8,13)]hexadecane C15H24O4 详情 详情

合成路线2

该中间体在本合成路线中的序号:(XXXII)

A short synthetic strategy utilized the cyclic thioketal (XXXIII), derived from d-menthone (XXXII) and 1,3-propanedithiol, as the chiral template. Stereospecific oxidation of dithiane (XXXIII) employing NaIO4 produced sulfoxide (XXXIV). The carbanion generated from sulfoxide (XXXIV) was stereoselectively alkylated by 5-bromopentanoic acid (XXXV) in the presence of TMEDA to furnish the trans alkylated compound (XXXVI). Finally, acidic hydrolysis of (XXXVI) formed the intermediate mercapto sulfinic acid (XXXVII) which spontaneously cyclized to the desired dithiolane derivative.

1 Menon, R.B.; et al.; Stereospecific synthesis of alpha-lipoic acid. Tetrahedron Lett 1987, 28, 44, 5313.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XXXII) 10208 L-Menthone; (2S,5R)-2-Isopropyl-5-methylcyclohexanone 14073-97-3 C10H18O 详情 详情
(XXXIII) 57961 (7R,10S)-7-isopropyl-10-methyl-1,5-dithiaspiro[5.5]undecane C13H24S2 详情 详情
(XXXIV) 57962 (6S,7R,10S)-7-isopropyl-10-methyl-5-thia-1-thioniaspiro[5.5]undecan-1-olate C13H24OS2 详情 详情
(XXXV) 57963 5-Bromo-n-valeric acid; 5-Bromopentanoic acid; 5-Bromovaleric acid 2067-33-6 C5H9BrO2 详情 详情
(XXXVI) 57964 (2R,6S,7R,10S)-2-(4-carboxybutyl)-7-isopropyl-10-methyl-5-thia-1-thioniaspiro[5.5]undecan-1-olate C18H32O3S2 详情 详情
(XXXVII) 57965 (6R)-6-(hydroxysulfanyl)-8-sulfanyloctanoic acid C8H16O3S2 详情 详情

合成路线3

该中间体在本合成路线中的序号:(XV)

The optically pure diol intermediate (VIII) can be obtained by several procedures. Aldol condensation of 3-chlorobenzaldehyde (XII) with the lithium enolate of ethyl acetate gives the hydroxy ester (XIII), which is reduced to racemic 1-(3-chlorophenyl)-1,3-propanediol (XIV) by means of LiAlH4 in Et2O. Ketalization of diol (XIV) with (-)-menthone (XV) employing trimethylsilyl triflate and hexamethyldisilazane produces the spiro ketal (XVI) as a diastereomeric mixture, from which the target (S)-diol (VIII) is obtained by fractional crystallization, followed by acidic ketal hydrolysis (1-3). In a different strategy utilizing an enantioselective reduction, 3’-chloroacetophenone (XVII) is condensed with diethyl carbonate by means of t-BuOK in THF to yield the keto ester (XVIII), which is selectively reduced to the (S)-hydroxy ester (XIX) by catalytic hydrogenation over a chiral ruthenium catalyst. After saponification of ester (XIX), the chiral hydroxy acid obtained (XX) is reduced to (VIII) with borane in THF. Similarly, the (S)-hydroxy acid (XX) can be produced by condensation of 3-chlorobenzoyl chloride (XXI) with the lithium enolate of trimethylsilyl acetate, followed by acidic desilylation to yield the keto acid (XXII), which is then reduced to (XX) utilizing (–)-B-chlorodiisopinocamphenylborane (DIP-Cl) in cold CH2Cl2 (1-5). In a further method, 3-chlorocinnamic acid (XXIII) is esterified with H2SO4/EtOH, followed by reduction with DIBAL to provide the cinnamyl alcohol (XXIV), which undergoes Sharpless asymmetric epoxidation to (XXV) with t-butyl hydroperoxide in the presence of (+)-diethyl tartrate. Reductive cleavage of the chiral epoxide obtained (XXV) by means of Red-Al then furnishes the target 1(S)-(3-chlorophenyl)-1,3-propanediol (VIII) (1, 2). Scheme 2.

1 Kopcho, J.J., Matelich, M.C., Reddy, K.R., Ugarkar, B.G. (Metabasis Therapeutics, Inc.). Process for preparation of cyclic prodrugs of PMEA and PMPA. JP 2005525422, US 2003225277, WO 2003095665.
2 Erion, M.D., Kopcho, J.J., Matelich, M.C., Reddy, K.R. (Metabasis Therapeutics, Inc.). Novel phosphonic acid based prodrugs of PMEA and its analogues. EP 1532157, US 2003229225, WO 2004037161.
3 Reddy, K.R., Matelich, M.C., Ugarkar, B.G. et al. HepDirect prodrugs of adefovir: Design, synthesis and optimization. 227th ACS Natl Meet (March 28-April 1, Anaheim) 2004, Abst MEDI- 27.
4 Martin, K. (Metabasis Therapeutics, Inc.). Lewis acid mediated synthesis of cyclic esters. CA 2565966, EP 1753762, US 2005282782, WO 2005123729.
5 Erion, M.D., Reddy, K.R., Boyer, S.H. et al. Design, synthesis, and characterization of a series of cytochrome P450 3A-activated prodrugs (HepDirect prodrugs) useful for targeting phospho(on)ate-based drugs to the liver. J Am Chem Soc 2004, 126(16): 5154-63.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XII) 13660 3-Chlorobenzaldehyde 587-04-2 C7H5ClO 详情 详情
(XIII) 65236     C11H13ClO3 详情 详情
(XIV) 65237 1(RS)-(3-chlorophenyl)-1,3-propanediol   C9H11ClO2 详情 详情
(XV) 10208 L-Menthone; (2S,5R)-2-Isopropyl-5-methylcyclohexanone 14073-97-3 C10H18O 详情 详情
(XVI) 65238     C19H27ClO2 详情 详情
(XVII) 15268 m-chloroacetophenone; 1-(3-chlorophenyl)-1-ethanone 99-02-5 C8H7ClO 详情 详情
(XVIII) 65239 ethyl 3-(3-chlorophenyl)-3-oxopropanoate   C11H11ClO3 详情 详情
(XIX) 65240     C11H13ClO3 详情 详情
(XX) 65241     C9H9ClO3 详情 详情
(XXI) 16687 3-chlorobenzoyl chloride 618-46-2 C7H4Cl2O 详情 详情
(XXII) 65242     C9H7ClO3 详情 详情
(XXIII) 65243 3-Chlorocinnamic acid 14473-90-6 C9H7ClO2 详情 详情
(XXIV) 65244     C9H9ClO 详情 详情
(XXV) 65245     C9H9ClO2 详情 详情

合成路线4

该中间体在本合成路线中的序号:(I)

 

1 Deshpande VH, Bhonsle JB, Pandey B, et al. 1994. New synthesis strategies towards(+) -artemisinin. Tetrahedron Lett, 35(30):5489~5492.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 10208 L-Menthone; (2S,5R)-2-Isopropyl-5-methylcyclohexanone 14073-97-3 C10H18O 详情 详情
(II) 10209 (3R,6S)-2-[(Dimethylamino)methyl]-6-isopropyl-3-methylcyclohexanone C13H25NO 详情 详情
(III) 10210 (4aS,5R,8S)-8-Isopropyl-5-methyl-4,4a,5,6,7,8-hexahydro-2(3H)-naphthalenone C14H22O 详情 详情
(IV) 10211 (1aS,4aS,5R,8S,8aS)-8-Isopropyl-5-methylhexahydro-1aH-naphtho[1,8a-b]oxiren-2(3H)-one C14H22O2 详情 详情
(V) 10212 (2S,4aS,5R,8S)-8-Isopropyl-5-methyloctahydro-2,8a(1H)-naphthalenediol C14H26O2 详情 详情
(VI) 10213 (2S,4aS,5R,8S,8aS)-8a-Hydroxy-8-isopropyl-5-methyldecahydro-2-naphthalenyl acetate C16H28O3 详情 详情
(VII) 67030 (3aS,6R,6aS,9S,10aR)-3,6-Dimethyldecahydro-2H-naphtho[8a,1-b]furan-9-ol   C14H24O2 详情 详情
(VIII) 10215 (3aS,6R,6aS,10aR)-3,6-Dimethyloctahydro-2H-naphtho[8a,1-b]furan-9(10H)-one C14H22O2 详情 详情
(IX) 10216 (4aS,5R,8S)-8-(2-Hydroxy-1-methylethyl)-5-methyl-4,4a,5,6,7,8-hexahydro-2(3H)-naphthalenone C14H22O2 详情 详情
(X) 10217 (4aS,5R,8R,8aS)-8-(2-Hydroxy-1-methylethyl)-5-methyloctahydro-2(1H)-naphthalenone C14H24O2 详情 详情
(XI) 10218 (4aS,5R,8R,8aS)-8-(2-Hydroxy-1-methylethyl)-2,5-dimethyldecahydro-2-naphthalenol C15H28O2 详情 详情
(XII) 10219 2-[(1R,4R,4aS,8aS)-7-hydroxy-4,7-dimethyldecahydro-1-naphthalenyl]propyl acetate C17H30O3 详情 详情
(XIII) 10220 2-[(1R,4R,4aS,8aS)-4,7-dimethyl-1,2,3,4,4a,5,6,8a-octahydro-1-naphthalenyl]propyl acetate C17H28O2 详情 详情
(XIV) 10221 2-[(1R,4R,4aS,8aS)-4,7-Dimethyl-1,2,3,4,4a,5,6,8a-octahydro-1-naphthalenyl]-1-propanol C15H26O 详情 详情
(XV) 67031 3-((4S,4aR,7S,8R)-4,7-dimethyl-4,4a,5,6,7,8-hexahydro-3H-isochromen-8-yl)propanoic acid   C14H22O3 详情 详情
(XVI) 10224 (1R,4S,5R,8S,9R,12R,13R)-1,5,9-Trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.0(4,13).0(8,13)]hexadecane C15H24O4 详情 详情
Extended Information